Toxicology screens are commonly used to detect substances, such as chemicals, drugs, or toxins, that could potentially affect a patient’s well-being or treatment strategy. The toxicology screening programs provided by Inspire Diagnostics’ Lab utilize molecular-based diagnostics to swiftly detect specific substances in both conventional urine samples and oral samples. Oral samples are particularly advantageous in cases where patients are unable to provide urine samples during testing or for facilities that prefer gender-neutral specimen collection methods.

Genetics testing is a valuable tool used to analyze an individual’s genetic makeup and identify potential genetic disorders, predispositions, or traits. At Inspire Diagnostics, our genetics testing programs encompass a broad range of molecular-based diagnostics, enabling the examination of various genetic markers and sequences. These tests can provide valuable insights into an individual’s inherited characteristics and the potential risks associated with certain genetic conditions. With our comprehensive genetics testing, patients can gain a deeper understanding of their genetic profile and make informed decisions regarding their health and well-being.

PCR-based testing continues to be the preferred method for accurately detecting ongoing infections in individuals, whether they display symptoms or not. Inspire Diagnostics offers clinical-grade RT-PCR tests of exceptional quality, adhering to the FDA’s current policy guidelines for COVID-19 testing conducted by CLIA-certified laboratories. By utilizing these advanced tests, we ensure reliable and precise identification of COVID-19 infections, enabling effective diagnosis and appropriate healthcare interventions.

The Inspire Diagnostics’ COVID-19 + Flu Combo testing is a comprehensive assay that integrates our highly reliable COVID PCR diagnostic test with an influenza A+B panel. This combined testing approach enables the identification of individual infections caused by either COVID-19 or influenza, as well as the detection of co-infections involving both viruses. Our testing solution has received authorization under the FDA’s emergency use authorization (EUA) specifically designated for COVID-19 diagnostic testing. With this advanced testing capability, we can effectively diagnose and differentiate between COVID-19 and influenza, aiding in appropriate treatment and management decisions.

The Inspire Diagnostics’ COVID-19 Antibody testing is a laboratory-based diagnostic method specifically developed to detect the presence of IgG antibodies in a patient’s blood sample. This test is designed to identify individuals who have been previously exposed to the SARS-CoV-2 virus, regardless of whether they displayed symptoms or remained asymptomatic. Our antibody testing adheres to the FDA’s current policy guidance for COVID-19 testing conducted by CLIA-certified laboratories, ensuring its compliance with rigorous quality standards. By utilizing this antibody testing, we can provide valuable insights into an individual’s immune response to COVID-19 and contribute to a more comprehensive understanding of the virus’s spread and impact.

The Inspire Diagnostics COVID-19 Antigen testing is a laboratory-based diagnostic method specifically designed to detect the presence of viral antigens related to the SARS-CoV-2 virus. This test enables the rapid identification of active infections in individuals, as it directly detects viral proteins in respiratory specimens. Our antigen testing provides reliable results within a short turnaround time, aiding in prompt diagnosis and appropriate patient management. By utilizing this antigen testing, we can effectively contribute to the early detection and control of COVID-19, helping to prevent further transmission of the virus.